The basic science and clinical studies carried out by hematology faculty cover a broad range of hematologic malignancies and blood disorders. Clinical investigators in the Division utilize discoveries from laboratories worldwide to develop and test novel therapeutic approaches to improve patient outcomes.
Study solves mystery of genetic mutation
Stanford researchers used genetic-editing tools and stem cell technology to uncover whether a genetic mutation linked to a heart rhythm disorder was benign or pathogenic.
Neurons quickly generated from blood
Fresh or frozen human blood samples can be directly transformed into patient-specific neurons to study disorders such as schizophrenia and autism, Stanford researchers find.
Can stem cells treat urinary incontinence?
Bertha Chen, MD, professor of obstetrics and gynecology, will receive nearly $6 million from the state stem cell agency to support research into the use of stem cells to treat urinary incontinence.
$11.9 million for anti-leukemia trial
The California Institute for Regenerative Medicine awarded Stanford researcher Crystal Mackall a grant to study immune cells genetically modified to attack two proteins on leukemia and lymphoma cells.
How liver regenerates itself
A subset of liver cells with high levels of telomerase renews the organ during normal cell turnover and after injury, according to Stanford researchers. The cells may also give rise to liver cancer.
Conferences and Workshops
Stanford Review of the 60th Annual American Society of Hematology Meeting 2019
Ritz-Carlton Hotel, Half Moon Bay, CA
New courses are added regularly— please check back often
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.